Biopsychosocial/economics Flashcards
SF-36
Short form health survey. Can be 36 qs, 8qs, 12qs.
8 sections : vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role function, social role function, mental health.
Each scale put onto 0-100 scale, lower score = more disability
Used in health economics for QALYs
Eq-5D
Euroquol 5 dimension. Rate mobility, self care, usual activities, pain/discomfort, anxiety/depression. Then rate globally on 100pt scale.
Used in health economics for QALYs
WHOQoL 100
WHO quality of life scale, BREF is shorter version). 4 Domains: physical health, psychological, social relationships, environment (includes finances, leisure)
AQoL-8D
Assessment of qualit of life, 8 dimensions.
Independent living, happiness, mental health, coping, relationships, self worth, pain, senses
MQOL
McGill quality of life questionnaire: 16 item on 1-10 scale. Covers 4 domains (psychological, physical symptoms, physical wellbeing and existential wellbeing). Geared towards palliative care/terminal conditions
ECOG
The ECOG performance status is a scale used to assess how a patient’s disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis
SS-QoL
The SS-QOL assesses health-related quality of life specific to stroke survivors.
Manchester short assessment
QoL in mental health conditions
PHQ-9
9 question instrument to screen for depression and assess severity. according to DSM IV. If mild then FU. Mod needs treatment plan. Mod/severe then drugs and counselling. Severe needs referral.
Beck’s inventory
21 item self scoring screen for depression
Cost minimisation analysis
Two options with equal effect on outcomes (e.g. equal increase in life expectancy) then looks for tech with lowest associated costs. Rarely used as outcome probably not exactly the same, and can’t be specified in prospective economic evaluation as wont know same outcomes beforehand
Cost effectiveness analysis
Two options compared by measuring same single outcome (e.g. life expectancy, reduction in stroke), and then incremental cost effectiveness ratio : ICER = cost of A-cost of B/ outcome from A-outcome from B. ICER = extra costs required to generate each additional unit of outcome if new replaces old.
Pros: easy, routinely measured parameters. Can use if two different outcomes and costs.
Cons: Only looks at health effects, doesn’t incorporate patient issues on qol
Cost utility analysis
Uses QALYs (where 1 = year in perfect health, 0=dead) QALY = life expectancy x health related QoL. Uses natural units (years alive). ICER can be used: Cost of new-cost of old/new QALY-oldQALY
Cost benefit analysis
Measures everything in cash value, so must be converted.
Pros: advantage over CUA and CEA that not just health outcomes, but social and infrastructure measurements. Can also evaluate standalone interventions (with no comparator).
Cons: very complex to determine, and involves monitorising everything.
Technosexuality
Can be an extension of biopower, with technological advances allowing increased surveliance on individuals. Includes contact tracing, dating apps, porn,digital access to test results and screening services
Sexual citizenship
Balance between disease eradification and treatment access, as well as citizens right to sexual enjoyment and wellbeing.